NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains
暂无分享,去创建一个
B. E. Black | J. Pascal | Marie-France Langelier | John M Pascal | Ben E Black | Levani Zandarashvili | M. Langelier | Pedro M Aguiar | Levani Zandarashvili | Pedro M. Aguiar
[1] L. Lehtiö,et al. Characterization of the DNA dependent activation of human ARTD2/PARP2 , 2016, Scientific Reports.
[2] D. Eisenberg,et al. Unusual conformation of nicotinamide adenine dinucleotide (NAD) bound to diphtheria toxin: A comparison with NAD bound to the oxidoreductase enzymes , 1997, Protein science : a publication of the Protein Society.
[3] G. Schulz,et al. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling. , 1998, Biochemistry.
[4] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[5] T. Ellenberger,et al. The rise and fall of poly(ADP-ribose): An enzymatic perspective. , 2015, DNA Repair.
[6] J. Pascal,et al. PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage , 2015, Nucleic acids research.
[7] J. Pascal,et al. A Third Zinc-binding Domain of Human Poly(ADP-ribose) Polymerase-1 Coordinates DNA-dependent Enzyme Activation* , 2008, Journal of Biological Chemistry.
[8] J. Pascal,et al. Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1 , 2015, Molecular cell.
[9] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[10] L. Pearl,et al. PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2BGlu2 , 2016, Nature Communications.
[11] N. Pannu,et al. REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.
[12] Jamin D Steffen,et al. PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain. , 2015, Molecular cell.
[13] L. Lehtiö,et al. Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors. , 2014, ACS medicinal chemistry letters.
[14] J. Pascal,et al. The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction* , 2010, The Journal of Biological Chemistry.
[15] Sejal Vyas,et al. New PARP targets for cancer therapy , 2014, Nature Reviews Cancer.
[16] S. Englander. Hydrogen exchange and mass spectrometry: A historical perspective , 2006, Journal of the American Society for Mass Spectrometry.
[17] J. Pascal,et al. Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1 , 2012, Science.
[18] J. Pascal,et al. Purification of human PARP-1 and PARP-1 domains from Escherichia coli for structural and biochemical analysis. , 2011, Methods in molecular biology.
[19] S. Asli Özgün-Koca,et al. A Historical Perspective from "a" to "c" , 2010 .
[20] Ziying Liu,et al. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes , 2017, Genes & development.
[21] J. Pascal,et al. Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA , 2011, The Journal of Biological Chemistry.
[22] R. Armen,et al. Structural Implications for Selective Targeting of PARPs , 2013, Front. Oncol..
[23] G. Poirier,et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. , 1999, The Biochemical journal.
[24] D Eisenberg,et al. Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide. , 1997, Advances in experimental medicine and biology.
[25] P. K. Glasoe,et al. USE OF GLASS ELECTRODES TO MEASURE ACIDITIES IN DEUTERIUM OXIDE1,2 , 1960 .
[26] J. Pascal,et al. Purification of DNA Damage-Dependent PARPs from E. coli for Structural and Biochemical Analysis. , 2017, Methods in molecular biology.
[27] Randy J. Read,et al. Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.
[28] Eric F. Johnson,et al. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). , 2009, Bioorganic & medicinal chemistry letters.
[29] Leland Mayne,et al. ExMS: Data Analysis for HX-MS Experiments , 2011, Journal of the American Society for Mass Spectrometry.
[30] Y. Pommier,et al. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. , 2012, Cancer research.
[31] J. Pinkner,et al. Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin. , 2011, Structure.
[32] F. Jiang,et al. Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5. , 2012, The Journal of organic chemistry.
[33] A. J. Shaka,et al. Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients , 1995 .
[34] J. Pascal,et al. PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1 , 2014, Nucleic acids research.
[35] A. Zatorski,et al. Chemical synthesis of benzamide adenine dinucleotide: inhibition of inosine monophosphate dehydrogenase (types I and II). , 1996, Journal of medicinal chemistry.
[36] A. Schnapp,et al. Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length. , 2002, Journal of molecular biology.
[37] A. R. Merrill,et al. The nature and character of the transition state for the ADP‐ribosyltransferase reaction , 2008, EMBO reports.
[38] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[39] G. Schulz,et al. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis. , 1998, Journal of molecular biology.